The emerging integrated PET imaging platform introduces three practical advances that will reshape clinical decision-making in osteosarcoma surgery. First, surgeons can now distinguish tumor tissue from healthy bone in real time during the procedure, eliminating uncertainty at the critical moment of resection. Second, immediate surgical margin assessment eliminates the traditional delay of waiting for pathology results, allowing surgeons to expand resection if needed while the patient remains anesthetized. Third, this molecular-level precision enables surgeons to maximize limb preservation by identifying the exact tumor boundary, reducing unnecessary removal of functional tissue. For patients facing osteosarcoma, these advances translate directly into better surgical outcomes and improved quality of life. The ability to balance complete tumor removal with limb preservation represents a fundamental shift in surgical strategy, particularly important for younger patients where long-term functionality and mobility are paramount concerns. Read the full article on GMJ Newsroom.
Was this article helpful?
